Prevalence of MRSA and associated factors among wound patients at Werabe Comprehensive Specialized Hospital, Ethiopia
The Journal of Infection in Developing Countries · 2026
DOI: 10.3855/jidc.21801 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2026. Verfasst von Nejato O Kerala und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Medicine and Health Sciences, Werabe University, Werabe, Ethiopia. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Wound Infection. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Staphylococcus aureus is a major global health threat due to its widespread distribution, ability to cause severe infections, and increasing antimicrobial resistance. It is responsible for a wide range of diseases, particularly skin and soft tissue infections, with wound infections being the most common. The emergence of methicillin-resistant S. aureus (MRSA) is of significant concern. However, local data on MRSA in wound infections remain limited. This study assessed the prevalence, antimicrobial susceptibility, and associated factors of MRSA among patients with wound infections at Werabe Comprehensive Specialized Hospital (WCSH). Methodology: A cross-sectional study was conducted from July 2023 to February 2024 involving 384 patients with wound infections. Wound swabs or pus samples were cultured on blood agar and mannitol salt agar. Identification of S. aureus was performed using standard biochemical tests, while MRSA detection used the cefoxitin disk diffusion method following CLSI guidelines. Data were collected using a semi-structured questionnaire, entered into Epi-info, and analyzed with SPSS. Logistic regression identified associations, with p < 0.05 considered significant.
Results
Of 384 participants, 90 (23.4%) had S. aureus; of which 24 (26.7%) were MRSA. Most S. aureus isolates (87.8%) and all MRSA were resistant to penicillin but fully sensitive to linezolid. All MRSA and 31.1% of S. aureus isolates were multidrug resistant. Hospital stay > 72 hours was significantly associated with MRSA (AOR = 3.06, p = 0.031).
Conclusions
There is a notable prevalence of MRSA with high multidrug resistance. Strengthening infection control, antimicrobial stewardship, and reducing prolonged hospital stays are recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, College of Medicine and Health Sciences, Werabe University, Werabe, Ethiopia.
- Department of Microbiology, Immunology, and Parasitology, School of BioMedicine and Laboratory Sciences, College of Health Sciences, Addis Ababa University, Ethiopia.
- Department of Medical Laboratory, Worabe Comprehensive Specialized Hospital, Werabe, Ethiopia.
- Department of Public Health, College of Medicine and Health Sciences, Werabe University, Werabe, Ethiopia.
- Department of Midwifery, College of Medicine and Health Sciences, Werabe University, Werabe, Ethiopia.
Zitieren
APA
Kerala, N. O., Kebede, H. B., Mosa, B. D., Wabe, Y. A., Negash, M. J., Halil, H. M., & Kalayu, A. A. (2026). Prevalence of MRSA and associated factors among wound patients at Werabe Comprehensive Specialized Hospital, Ethiopia. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.21801
Vancouver
Kerala NO, Kebede HB, Mosa BD, Wabe YA, Negash MJ, Halil HM, et al. Prevalence of MRSA and associated factors among wound patients at Werabe Comprehensive Specialized Hospital, Ethiopia. The Journal of Infection in Developing Countries. 2026. doi:10.3855/jidc.21801
BibTeX
@article{Kerala2026,
author = {Kerala, Nejato O and Kebede, Habtamu B and Mosa, Behre D and Wabe, Yasin A and Negash, Musa J and Halil, Hassen M and Kalayu, Alem A},
title = {Prevalence of MRSA and associated factors among wound patients at Werabe Comprehensive Specialized Hospital, Ethiopia},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
doi = {10.3855/jidc.21801}
}
EUVIMED